ReviewAdvances in ophthalmology practice and research
Research progress of in vivo measurement methods of myopia sclera biomechanics.
Review in Advances in ophthalmology practice and research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The study of the development mechanism of myopia involves many aspects, of which the remodeling and biomechanical changes of the sclera are currently recognized as some of the more important mechanisms. In recent years, new progress has been made in in vivo and ex vivo measurement methods to characterize scleral biomechanics. However, because ex vivo measurement methods cannot be used on the in vivo eyeball, there is still a lack of a reliable in vivo scleral biomechanical measurement method to assess the trend of myopia progression in clinical practice. Main text: In this paper, the research progress of existing in vivo measurement methods of scleral biomechanics in myopia is reviewed, and the advantages and limitations of these methods are discussed. The purpose is to comprehensively introduce the current development status of in vivo measurement methods of scleral biomechanics, look forward to their clinical application and development, and to explore new directions and ideas for the application of scleral biomechanics in the prevention and control of myopia. Conclusions: The review shows that the most urgent problem is to further prove and verify that the biomechanical properties of the sclera can be measured with sufficient sensitivity and accuracy in vivo. Its safety and feasibility in clinical application also need to be considered. Future studies should investigate the multi-level and multi-scale biomechanical properties of the myopic sclera, and develop non-contact and non-invasive in vivo measurement techniques to provide more methods for myopia prevention and control and early screening of myopia in adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.